Obesity Surgery

, Volume 29, Issue 11, pp 3674–3679 | Cite as

Helicobacter Pylori Infection Prevalence and Histopathologic Findings in Laparoscopic Sleeve Gastrectomy

  • Gülay Turan
  • Servet KocaözEmail author
Original Contributions



Helicobacter pylori (H. pylori) is a type of bacteria that affects more than half of the world’s population and has been associated with gastritis. The relationship between H. pylori and obesity is controversial. Laparoscopic sleeve gastrectomy (LSG) is the most commonly used surgery for morbidly obese patients. The aim of this study was to investigate the rate of H. pylori in patients undergoing LSG.


Biopsy specimens of 32,743 patients who underwent esophagogastroduodenoscopy (EGD) and resection materials from 1257 patients who underwent LSG were examined histopathologically. The relationships between body mass index (BMI), age, gender, H. pylori infection, and intestinal metaplasia (IM) were investigated in patients with gastritis.


In patients undergoing EGD, the association of H. pylori infection was found to be increased in males and the elderly (p < 0.001). The presence of gastritis and IM was significantly higher with H. pylori infection (p < 0.001 and p = 0.001, respectively). H. pylori infection was significantly higher in patients over the age of 41 years (p < 0.001). There was no significant difference between the results of H. pylori before and after LSG surgery (p = 0.923). The presence of H. pylori together with gastritis and IM was found to be significant (p < 0.001).


H. pylori infection increases with age. No significant difference was found in the examination for H. pylori before and after LSG surgery. In addition, no relationship was found between H. pylori and excess weight. However, due to the low average age of patients who underwent LSG, further studies are needed in this area.


Obesity Sleeve gastrectomy Pathologic findings Helicobacter pylori 


Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.


  1. 1.
    Malfertheiner P, Megraud F, O’Morain CA, et al. European Helicobacter Study Group. Management of Helicobacter pylori infection--the Maastricht IV/ Florence consensus report. Gut. 2012;61(5):646–64.CrossRefGoogle Scholar
  2. 2.
    Tadege T, Mengistu Y, Desta K, et al. Seroprevelance of Helicobacter pylori infection in and its relationship with ABO blood groups. Ethiop J Health Dev. 2005;19:55–9.CrossRefGoogle Scholar
  3. 3.
    Kanbay M, Gür G, Arslan H, et al. The relationship of ABO blood group, age, gender, smoking, and Helicobacter pylori infection. Dig Dis Sci. 2005;50(7):1214–7.CrossRefGoogle Scholar
  4. 4.
    Cherdantseva LA, Potapova OV, Sharkova TV, et al. Association of Helicobacter pylori and iNOS production by macrophages and lymphocytes in the gastric mucosa in chronic gastritis. J Immunol Res. 2014;2014:762514. 1, 4CrossRefGoogle Scholar
  5. 5.
    Khatoon J, Rai RP, Prasad KN. Role of Helicobacter pylori in gastric cancer: updates. World J Gastrointest Oncol. 2016;8(2):147–58.CrossRefGoogle Scholar
  6. 6.
    Huang TC, Lee CL. Diagnosis, treatment, and outcome in patients with bleeding peptic ulcers and Helicobacter pylori infections. Biomed Res Int. 2014;2014:658108.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Asano N, Iijima K, Koike T, et al. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: a review. World J Gastroenterol. 2015;21(26):8014–20.CrossRefGoogle Scholar
  8. 8.
    Başara BB, Çağlar İS, Aygün A, Özdemir TA, Kulali B, Uzun SB et al. Republic of Turkey Ministry of Health, Health statistics year book 2017. SB-SAGEM-, Ankara 2018;1106:38–43.Google Scholar
  9. 9.
    Carabotti M, D’Ercole C, Iossa A, et al. Helicobacter pylori infection in obesity and its clinical outcome after bariatric surgery. World J Gastroenterol. 2014;20(3):647–53.CrossRefGoogle Scholar
  10. 10.
    Wu MS, Lee WJ, Wang HH, et al. A case-control study of association of Helicobacter pylori infection with morbid obesity in Taiwan. Arch Intern Med. 2005;165(13):1552–5.CrossRefGoogle Scholar
  11. 11.
    Arslan E, Atilgan H, Yavaşoğlu I. The prevalence of Helicobacter pylori in obese subjects. Eur J Intern Med. 2009;20(7):695–7.CrossRefGoogle Scholar
  12. 12.
    Chen LW, Kuo SF, Chen CH, et al. A community-based study on the association between Helicobacter pylori infection and obesity. Sci Rep. 2018;8(1):10746.CrossRefGoogle Scholar
  13. 13.
    Šebunova N, Štšepetova J, Sillakivi T, Mändar R. The prevalence of Helicobacter pylori in Estonian bariatric surgery patients. Int J Mol Sci. 2018;19(2)CrossRefGoogle Scholar
  14. 14.
    Lane JA, Murray LJ, Harvey IM, et al. Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study. Aliment Pharmacol Ther. 2011;33(8):922–9.CrossRefGoogle Scholar
  15. 15.
    Jang EJ, Park SW, Park JS, et al. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease. J Gastroenterol Hepatol. 2008;23(Suppl 2):S278–85.CrossRefGoogle Scholar
  16. 16.
    Zhang Y, Du T, Chen X, et al. Association between Helicobacter pylori infection and overweight or obesity in a Chinese population. J Infect Dev Ctries. 2015;9(9):945–53.CrossRefGoogle Scholar
  17. 17.
    Keren D, Matter I, Rainis T, et al. Sleeve gastrectomy leads to Helicobacter pylori eradication. Obes Surg. 2009;19(6):751–6.CrossRefGoogle Scholar
  18. 18.
    Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20(10):1161–81.CrossRefGoogle Scholar
  19. 19.
    Danciu M, Simion L, Poroch V, et al. The role of histological evaluation of Helicobacter pylori infection in obese patients referred to laparoscopic sleeve gastrectomy. Romanian J Morphol Embryol. 2016;57(4):1303–11.Google Scholar
  20. 20.
    Almazeedi S, Al-Sabah S, Alshammari D, et al. The impact of Helicobacter pylori on the complications of laparoscopic sleeve gastrectomy. Obes Surg. 2014;24(3):412–5.CrossRefGoogle Scholar
  21. 21.
    Albawardi A, Almarzooqi S, Torab FC. Helicobacter pylori in sleeve gastrectomies: prevalence and rate of complications. Int J Clin Exp Med. 2013;6(2):140–3.PubMedPubMedCentralGoogle Scholar
  22. 22.
    Xu MY, Liu L, Yuan BS, et al. Association of obesity with Helicobacter pylori infection: a retrospective study. World J Gastroenterol. 2017;23(15):2750–6.CrossRefGoogle Scholar
  23. 23.
    Brownlee AR, Bromberg E, Roslin MS. Outcomes in patients with Helicobacter pylori undergoing laparoscopic sleeve gastrectomy. Obes Surg. 2015;25(12):2276–9.CrossRefGoogle Scholar
  24. 24.
    Rossetti G, Moccia F, Marra T, et al. Does helicobacter pylori infection have influence on outcome of laparoscopic sleeve gastrectomy for morbid obesity? Int J Surg. 2014;12(Suppl 1):S68–71.CrossRefGoogle Scholar
  25. 25.
    Onzi TR, d’Acampora AJ, de Araújo FM, et al. Gastric histopathology in laparoscopic sleeve gastrectomy: pre- and post-operative comparison. Obes Surg. 2014;24(3):371–6.CrossRefGoogle Scholar
  26. 26.
    Loewen M, Giovanni J, Barba C. Screening endoscopy before bariatric surgery: a series of 448 patients. Surg Obes Relat Dis. 2008;4(6):709–12.CrossRefGoogle Scholar
  27. 27.
    Küper MA, Kratt T, Kramer KM, et al. Effort, safety, and findings of routine preoperative endoscopic evaluation of morbidly obese patients undergoing bariatric surgery. Surg Endosc. 2010;24(8):1996–2001.CrossRefGoogle Scholar
  28. 28.
    Franklin AL, Koeck ES, Hamrick MC, et al. Prevalence of chronic gastritis or Helicobacter pylori infection in adolescent sleeve gastrectomy patients does not correlate with symptoms or surgical outcomes. Surg Infect. 2015;16(4):401–4.CrossRefGoogle Scholar
  29. 29.
    Wildner-Christensen M, Hansen JM, De Muckadell OB. Risk factors for dyspepsia in a general population: non-steroidal anti-inflammatory drugs, cigarette smoking and unemployment are more important than Helicobacter pylori infection. Scand J Gastroenterol. 2006;41(2):149–54.CrossRefGoogle Scholar
  30. 30.
    Safaan T, Bashah M, El Ansari W, et al. Histopathological changes in laparoscopic sleeve gastrectomy specimens: prevalence, risk factors, and value of routine histopathologic examination. Obes Surg. 2017;27(7):1741–9.CrossRefGoogle Scholar
  31. 31.
    Raess PW, Baird-Howell M, Aggarwal R, et al. Vertical sleeve gastrectomy specimens have a high prevalence of unexpected histopathologic findings requiring additional clinical management. Surg Obes Relat Dis. 2015;11(5):1020–3.CrossRefGoogle Scholar
  32. 32.
    Sauerland S, Angrisani L, Belachew M, et al. European Association for Endoscopic Surgery. Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc. 2005;19(2):200–21.CrossRefGoogle Scholar
  33. 33.
    Mao XY, Xu SF, Liu Q, et al. Anatomical predilection of intestinal metaplasia based on 78,335 endoscopic cases. Saudi J Gastroenterol. 2016;22(2):154–60.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.The Department of Medical Pathology, Faculty of MedicineBalıkesir UniversityBalıkesirTurkey
  2. 2.Department of General SurgeryAnkara Atatürk Eğitim ve Araştırma Hastanesi Üniversiteler mahAnkaraTurkey

Personalised recommendations